These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25373124)

  • 1. Metformin for weight loss and control in patients with mood disorder.
    Linneke JL; Jørgensen GK; Csillag C
    J Clin Psychiatry; 2014 Oct; 75(10):e1140-1. PubMed ID: 25373124
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin provides weight reduction for hospitalized patients receiving polypharmacy.
    Winsberg B; Yeager C; Hobbs B; Wei R; Elangovan N
    J Clin Psychopharmacol; 2010 Jun; 30(3):345-6. PubMed ID: 20473081
    [No Abstract]   [Full Text] [Related]  

  • 3. Metformin and lifestyle changes help people taking antipsychotics lose weight.
    Harv Ment Health Lett; 2008 Apr; 24(10):7. PubMed ID: 18651997
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction between weight and medications in psychological illnesses of children.
    Apter A; Steingart L
    World Rev Nutr Diet; 2013; 106():174-80. PubMed ID: 23428698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can metformin or rosiglitazone reduce metabolic side effects associated with atypical antipsychotics?
    Housel AK; Waterbury N; Argo TR
    Issues Ment Health Nurs; 2009 Dec; 30(12):803-5. PubMed ID: 19916816
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing weight gain for patients taking antipsychotic medications: The potential role for early use of metformin.
    Hendrick V; Dasher R; Gitlin M; Parsi M
    Ann Clin Psychiatry; 2017 May; 29(2):120-124. PubMed ID: 28463344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-emergent tardive dyskinesia with quetiapine in mood disorders.
    Sharma V
    J Clin Psychopharmacol; 2003 Aug; 23(4):415-7. PubMed ID: 12920421
    [No Abstract]   [Full Text] [Related]  

  • 9. Metformin-Induced Type 1 Hypersensitivity in a Child with Antipsychotic-Induced Weight Gain.
    Mennella C; Dickstein DP
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):106-107. PubMed ID: 27548055
    [No Abstract]   [Full Text] [Related]  

  • 10. Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis.
    Björkhem-Bergman L; Asplund AB; Lindh JD
    J Psychopharmacol; 2011 Mar; 25(3):299-305. PubMed ID: 20080925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drugs that make gain weight or make lose weight].
    Chanson P; Pariente A
    Rev Prat; 2015 Apr; 65(4):474. PubMed ID: 26058187
    [No Abstract]   [Full Text] [Related]  

  • 12. The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a review.
    Khan AY; Macaluso M; McHale RJ; Dahmen MM; Girrens K; Ali F
    J Psychiatr Pract; 2010 Sep; 16(5):289-96. PubMed ID: 20859106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?
    Pringsheim T; Gardner D; Patten SB
    BMJ; 2015 Mar; 350():h569. PubMed ID: 25739588
    [No Abstract]   [Full Text] [Related]  

  • 14. Time course and dose effect of metformin on weight in patients with different disease states.
    Chen X; Wang DD; Li ZP
    Expert Rev Clin Pharmacol; 2020 Oct; 13(10):1169-1177. PubMed ID: 32940086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.
    Newall H; Myles N; Ward PB; Samaras K; Shiers D; Curtis J
    Int Clin Psychopharmacol; 2012 Mar; 27(2):69-75. PubMed ID: 21979790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight gain--as possible predictor of metabolic syndrome.
    Grahovac T; Ružić K; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
    Psychiatr Danub; 2011 Mar; 23(1):105-7. PubMed ID: 21448110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin in an Adolescent with Significant Weight Gain.
    Salau M; Adam B; Coffey BJ
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):589-92. PubMed ID: 26375769
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin in obesity associated with antipsychotic drug administration: a pilot study.
    Baptista T; Hernàndez L; Prieto LA; Boyero EC; de Mendoza S
    J Clin Psychiatry; 2001 Aug; 62(8):653-5. PubMed ID: 11561940
    [No Abstract]   [Full Text] [Related]  

  • 20. Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes.
    Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
    Diabet Med; 2012 Dec; 29(12):1515-23. PubMed ID: 22540883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.